GERN
Geron Corp
Price:  
3.66 
USD
Volume:  
5,825,272.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-334.9%
Upside

As of 2024-05-23, the Relative Valuation of Geron Corp (GERN) is (8.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.66 USD, the upside of Geron Corp based on Relative Valuation is -334.9%.

The range of the Relative Valuation is (4.60) - (8.62) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.4x - 28.5x 28.1x
Forward P/E multiples 11.9x - 25.1x 22.0x
Fair Price (4.60) - (8.62) (8.60)
Upside -225.6% - -335.5% -334.9%
3.66 USD
Stock Price
(8.60) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2024-05-22 -10.67
2024-05-21 -10.78
2024-05-20 -10.87
2024-05-17 -11.10
2024-05-16 -11.37
2024-05-15 -11.37
2024-05-14 -10.72
2024-05-13 -10.90
2024-05-10 -11.07
2024-05-09 -11.31
2024-05-08 -11.10
2024-05-07 -11.28
2024-05-06 -10.87
2024-05-03 -11.45
2024-05-02 -11.51
2024-05-01 -11.89
2024-04-30 -11.45
2024-04-29 -12.06
2024-04-26 -11.04
2024-04-25 -10.37
2024-04-24 -10.43
2024-04-23 -10.20
2024-04-22 -10.87
2024-04-19 -10.75
2024-04-18 -10.87
2024-04-17 -10.72
2024-04-16 -10.43
2024-04-15 -10.05
2024-04-12 -10.61
2024-04-11 -10.99
2024-04-10 -10.02
2024-04-09 -10.00
2024-04-08 -9.70
2024-04-05 -9.67
2024-04-04 -9.35
2024-04-03 -9.35
2024-04-02 -9.03
2024-04-01 -9.24
2024-03-28 -9.62
2024-03-27 -9.65
2024-03-26 -9.62
2024-03-25 -9.50
2024-03-22 -9.65
2024-03-21 -9.70
2024-03-20 -10.02
2024-03-19 -9.50
2024-03-18 -9.25
2024-03-15 -9.79
2024-03-13 -5.10
2024-03-12 -5.48